Senator Burr warned the FDA that until the Senate is okay with their response to the infant formula crisis, and present a plan to prevent it in the future, the Generic Drug User Fee Authorization bill might be put on hold.
Solar and steel tariffs helped the industry expand. Here is where the naysayers were wrong about rising prices and market destruction due to anti-dumping charges and other trade remedies.
The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
The Senate Intelligence Committee discusses China’s strategy for economic and technological dominance. Senator Marco Rubio wonders if China will hold supply chains hostage.
The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.
A bipartisan group of Republicans and Democrats support including the pro-China trade provision in the Senate USICA bill in the new Bipartisan Innovation Act.
An overvalued dollar is helping to exacerbate the country’s largest-ever trade deficit in goods. The U.S. is on pace for $1.1 trillion deficit in 2022.
A House Foreign Affairs Committee hearing warned against creating economic dead zones in rush to switch to renewables.
The Senate Armed Services Committee heard testimony this week from defense industry experts warning about the declining domestic market share for microelectronics.
Janet Yellen tells The Atlantic Council that the U.S. needs more resilient supply chains. But judging by her speech, reshoring was not part of the solution.